Back
Neuronetics, Inc. 10K Form
Sell
31
STIM
Neuronetics, Inc.
Last Price:
$1.41
Seasonality Move:
46.07%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-07 | 10Q | STIM/Neuronetics, Inc. Quarterly |
| 2023-11-07 | 10Q | STIM/Neuronetics, Inc. Quarterly |
| 2023-08-08 | 10Q | STIM/Neuronetics, Inc. Quarterly |
| 2023-05-15 | 10Q | STIM/Neuronetics, Inc. Quarterly |
| 2022-11-08 | 10Q | STIM/Neuronetics, Inc. Quarterly |
| 2022-08-02 | 10Q | STIM/Neuronetics, Inc. Quarterly |
Receive STIM News And Ratings
See the #1 stock for the next 7 days that we like better than STIM
STIM Financial Statistics
Sales & Book Value
| Annual Sales: | $74.9M |
|---|---|
| Cash Flow: | $-899K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.40 |
| Price / Book: | 3.5 |
Profitability
| EPS (TTM): | -0.82500 |
|---|---|
| Net Income (TTM): | $-44.1M |
| Gross Margin: | $52.1M |
| Return on Equity: | -153.53% |
| Return on Assets: | -34.6% |
Neuronetics, Inc. Earnings Forecast
Key Neuronetics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 10 years for STIM is 69.55%.
-
The Selling, General & Administrative Expenses for STIM have been equal to 101.42% of Gross Profit Margin.
-
The Research & Development expenses have been 17.05% of Revenue.
-
The Net Earning history of STIM is -58.39% of Total Revenues.
-
Per Share Earnings over the last 10 years have been positive in 5 years.
Neuronetics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | STIM |
| CUSIP: | 64131A |
| Website: | neurostar.com |
Debt
| Debt-to-Equity Ratio: | 3.32 |
|---|---|
| Current Ratio: | 2.24 |
| Quick Ratio: | 1.9 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
STIM Technical Analysis vs Fundamental Analysis
Sell
31
Neuronetics, Inc. (STIM)
is a Sell
Is Neuronetics, Inc. a Buy or a Sell?
-
Neuronetics, Inc. stock is rated a SellThe current Neuronetics, Inc. [STIM] share price is $1.40. The Score for STIM is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.